ArdorComm Media Group

Shareholder Approval

Frontier Communications Shareholders Approve Merger with Verizon in $38.50/Share All-Cash Deal

Frontier Communications (NASDAQ: FYBR) announced that its shareholders have approved the acquisition by Verizon Communications Inc. (NYSE, NASDAQ: VZ) in a recent vote, with approximately 63% in favor. This merger agreement, first revealed on September 5, 2024, values Frontier at $38.50 per share in cash—a 37% premium above its pre-announcement share price. Pending regulatory approvals, the transaction is expected to close by Q1 2026. Frontier CEO Nick Jeffery expressed confidence in the combined entity’s potential to expand premium fiber services nationwide, benefiting millions more consumers through the expanded network. Frontier, the U.S.’s largest pure-play fiber provider, continues its commitment to “Building Gigabit America®,” delivering high-speed broadband connectivity to drive productivity for homes and businesses. Frontier shareholders’ positive vote and Verizon’s strategic acquisition align both companies’ goals in providing reliable, high-speed internet access to underserved areas. The forward-looking statements included in Frontier’s communication highlight factors that could impact the merger’s completion, including regulatory and shareholder approval, potential competing acquisition offers, and the transaction’s effect on business operations. As of now, the combined expertise of both companies is expected to accelerate fiber network reach and meet growing demands for high-speed connectivity across the U.S. Source: Business Wire Photo Credit: Business Wire

McKesson to Acquire Controlling Interest in Florida Cancer Specialists’ Management Services for $2.49 Billion

McKesson Corp. has announced its agreement to acquire a controlling stake in Community Oncology Revitalization Enterprise Ventures LLC (Core Ventures) for $2.49 billion in cash. Core Ventures, a business and administrative services organization established by Florida Cancer Specialists & Research Institute (FCS), supports nearly 100 FCS clinics across Florida. The transaction will give McKesson approximately 70% ownership, with FCS physicians retaining a minority interest. Core Ventures offers operational and advisory services that align practice locations, ancillary services, and patient care across FCS. The acquisition will integrate Core Ventures into McKesson’s Oncology platform, with financials reported under the US Pharmaceutical segment. FCS, which operates with more than 250 physicians and 280 advanced practice providers, will remain independently owned but will join McKesson’s US Oncology Network, enhancing community-based cancer care. “This acquisition strengthens our ability to deliver advanced treatments and enhance care experiences while reducing costs,” said Brian Tyler, CEO of McKesson. “Our collaboration with FCS and Core Ventures aligns with our commitment to improving patient outcomes and expanding access to quality care.” FCS CEO Nathan Walcker echoed the sentiment: “This partnership with McKesson and joining The US Oncology Network is a significant step for FCS. It enhances our mission to deliver patient-centered cancer care and bring cutting-edge medicine into communities across Florida.” The deal is subject to regulatory clearances and standard closing conditions. Source: hcinnovationgroup